iShares Genomics Immunology and Healthcare ETF

The iShares Genomics Immunology and Healthcare ETF is an exchange-traded fund that provides exposure to global companies at the forefront of genomics, immunology, and bioengineering innovation. The fund tracks a market-cap-weighted index of firms involved in these rapidly advancing fields, spanning the full value chain from research and development to commercialization. Its portfolio is heavily concentrated in the healthcare sector, with a focus on companies driving breakthroughs in genetic therapies, immunotherapies, and advanced biopharmaceuticals. The ETF offers investors a way to participate in the long-term growth potential of these transformative technologies, which are reshaping medicine and healthcare delivery worldwide. Managed by BlackRock, the fund is designed for those seeking targeted exposure to the scientific and technological advancements shaping the future of health and biotechnology.